Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis
ConclusionsGuselkumab-treated patients with psoriasis and self-reported PsA showed meaningful improvements in nail, scalp, and palmoplantar psoriasis.Trial RegistrationVOYAGE-1 (ClinicalTrials.gov Identifier: NCT02207231) and VOYAGE-2 (ClinicalTrials.gov Identifier: NCT02207244).
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Arthritis | Dermatology | Humira | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin | Study